Literature DB >> 15649699

Impaired Cu/Zn-SOD activity contributes to increased oxidative damage in APP transgenic mice.

Katrin Schuessel1, Stephanie Schäfer, Thomas A Bayer, Christian Czech, Laurent Pradier, Franz Müller-Spahn, Walter E Müller, Anne Eckert.   

Abstract

Oxidative stress plays an important role in the pathogenesis of Alzheimer's disease. To determine which mechanisms cause the origin of oxidative damage, we analyzed enzymatic antioxidant defense (Cu/Zn-superoxide dismutase Cu/Zn-SOD, glutathione peroxidase GPx and glutathione reductase GR) and lipid peroxidation products malondialdehyde MDA and 4-hydroxynonenal HNE in two different APP transgenic mouse models at 3-4 and 12-15 months of age. No changes in any parameter were observed in brains from PDGF-APP695(SDL) mice, which have low levels of Abeta and no plaque load. In contrast, Thy1-APP751(SL) mice show high Abeta accumulation with aging and plaques from an age of 6 months. In brains of these mice, HNE levels were increased at 3 months (female transgenic mice) and at 12 months (both gender), that is, before and after plaque deposition, and the activity of Cu/Zn-SOD was reduced. Interestingly, beta-amyloidogenic cleavage of APP was increased in female Thy1-APP751(SL) mice, which also showed increased HNE levels with simultaneously reduced Cu/Zn-SOD activity earlier than male Thy1-APP751(SL) mice. Our results demonstrate that impaired Cu/Zn-SOD activity contributes to oxidative damage in Thy1-APP751(SL) transgenic mice, and these findings are closely linked to increased beta-amyloidogenic cleavage of APP.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15649699     DOI: 10.1016/j.nbd.2004.09.003

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  33 in total

1.  beta-Amyloid infusion results in delayed and age-dependent learning deficits without role of inflammation or beta-amyloid deposits.

Authors:  Tarja Malm; Michael Ort; Leena Tähtivaara; Niko Jukarainen; Gundars Goldsteins; Jukka Puoliväli; Antti Nurmi; Raimo Pussinen; Toni Ahtoniemi; Taina-Kaisa Miettinen; Katja Kanninen; Suvi Leskinen; Nina Vartiainen; Juha Yrjänheikki; Reino Laatikainen; Marni E Harris-White; Milla Koistinaho; Sally A Frautschy; Jan Bures; Jari Koistinaho
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-24       Impact factor: 11.205

2.  Membrane-mediated amyloidogenesis and the promotion of oxidative lipid damage by amyloid beta proteins.

Authors:  Ian V J Murray; Liu Liu; Hiroaki Komatsu; Kunihiro Uryu; Gang Xiao; John A Lawson; Paul H Axelsen
Journal:  J Biol Chem       Date:  2007-01-24       Impact factor: 5.157

3.  Increased T-cell reactivity and elevated levels of CD8+ memory T-cells in Alzheimer's disease-patients and T-cell hyporeactivity in an Alzheimer's disease-mouse model: implications for immunotherapy.

Authors:  Katharina Schindowski; Anne Eckert; Jürgen Peters; Corinna Gorriz; Uta Schramm; Thomas Weinandi; Konrad Maurer; Lutz Frölich; Walter E Müller
Journal:  Neuromolecular Med       Date:  2007-10-26       Impact factor: 3.843

4.  Antioxidant proteins TSA and PAG interact synergistically with Presenilin to modulate Notch signaling in Drosophila.

Authors:  Michael F Wangler; Lawrence T Reiter; Georgianna Zimm; Jennifer Trimble-Morgan; Jane Wu; Ethan Bier
Journal:  Protein Cell       Date:  2011-08-06       Impact factor: 14.870

5.  A selective role for ARMS/Kidins220 scaffold protein in spatial memory and trophic support of entorhinal and frontal cortical neurons.

Authors:  Aine M Duffy; Michael J Schaner; Synphen H Wu; Agnieszka Staniszewski; Asok Kumar; Juan Carlos Arévalo; Ottavio Arancio; Moses V Chao; Helen E Scharfman
Journal:  Exp Neurol       Date:  2011-03-16       Impact factor: 5.330

6.  Gender dependent APP processing in a transgenic mouse model of Alzheimer's disease.

Authors:  S Schäfer; O Wirths; G Multhaup; T A Bayer
Journal:  J Neural Transm (Vienna)       Date:  2006-10-31       Impact factor: 3.575

7.  Brain mitochondrial dysfunction in ovariectomized mice injected with D-galactose.

Authors:  Yang Su; Hao Sun; Jie Fang; Gang Hu; Ming Xiao
Journal:  Neurochem Res       Date:  2009-09-24       Impact factor: 3.996

Review 8.  Antioxidants in central nervous system diseases: preclinical promise and translational challenges.

Authors:  Chandrashekhar D Kamat; Sunyana Gadal; Molina Mhatre; Kelly S Williamson; Quentin N Pye; Kenneth Hensley
Journal:  J Alzheimers Dis       Date:  2008-11       Impact factor: 4.472

Review 9.  Convergence of amyloid-beta and tau pathologies on mitochondria in vivo.

Authors:  Anne Eckert; Kathrin L Schulz; Virginie Rhein; Jürgen Götz
Journal:  Mol Neurobiol       Date:  2010-03-09       Impact factor: 5.590

Review 10.  Superoxide dismutases: a physiopharmacological update.

Authors:  A Valdivia; S Pérez-Alvarez; J D Aroca-Aguilar; I Ikuta; J Jordán
Journal:  J Physiol Biochem       Date:  2009-06       Impact factor: 4.158

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.